Neuro diseases Flashcards

1
Q

Define Neurodegeneration and Neurodegenerative disease

A
  • Neurodegeneration = neuro (relating to neurons) + degeneration (progressive loss)
  • Neurodegenerative disease = any disease caused by neurodegeneration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do neuro diseases affect?

When do they begin?

A

• Affect the CNS or PNS (or both)

  • Begin at any stage of life
  • The most common ones are associated with ageing
  • Rarer types of neurodegenerative disease start in childhood or even from birth
  • Earlier age of onset = greater genetic contribution
  • Later age of onset = more likely a sporadic (or idiopathic) disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Have a look at some examples

A

On table

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Are Neurodegenerative diseases heterogenous and why?

A

• Neurodegenerative diseases are highly heterogeneous (varied in presentation), the reasons for this are:
o Some disease names are really umbrella terms

Conditions with overlapping phenotypes, but distinct causes (e.g. at least 25 types of SCA from mutations in different genes)
o Some diseases are inherently pleiotropic

Symptoms manifest differently in different people
(e.g. Parkinson’s disease symptoms unique to individual)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the patterns of these diseases?

A
  1. Molecular impairment somewhere in the cell
  2. Decreased transmission at synapse
  3. “Dying back” of neurites (axons and/or dendrites)
  4. Cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the distance between axon terminal and nucleus

A

a neuron’s “Achilles heel”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the common features of these diseases?

A
  • Protein aggregation (“proteinopathies”)
  • Lysosomal dysfunction
  • Mitochondrial dysfunction
  • Associated inflammation via activation of glia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the clinical and research problems?

A

• Neurodegenerative diseases rarely manifest overt signs and symptoms until long after neurodegeneration has begun
o Early treatment is impossible without early diagnosis
o Therapeutic challenge is considerable
• For CNS disorders, studies of affected tissue is very difficult until death
o Advanced brain pathology is of little help to understanding the causes
• Neurodegenerative diseases remain incurable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is dementia?

A
  • A decline in memory and other cognitive functions that impair quality of life
  • Impairments in dementia are distinct from “normal” cognitive lapses, e.g.

Normal ageing = gradual decline in normal cognition, gradual changes in personality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the PATHOLOGICAL HALLMARKS of Alzheimers?

A

On images

Proteinopathies
•	Amyloid plaques
•	Extracellular protein aggregates
•	Enriched in Aβ peptides
Neurofibrillary tangles
•	Also called paired helical filaments
•	Intracellular protein aggregates
•	Enriched in Tau protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What causes alzheimers disease?

A

Aβ peptide is cleaved from a transmembrane protein called amyloid beta precursor protein (APP) by proteases

Mutations to three proteins involved in Aβ peptide processing are known to cause rare early onset forms of Alzheimer’s
• APP
• PSEN1 - Presenilin-1 and Presenilin-2; both a components of γ-secretase
• PSEN2 - Presenilin-1 and Presenilin-2; both a components of γ-secretase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is tau and how does it cause alzheimers?

A
  • Tau normally binds microtubules in axons
  • Hyperphosphorylated tau is displaced causing:

Tangles
Destabilised microtubules

In typical late onset AD (i.e. not genetic forms of AD), neurofibrillary tangles are:
• Seen before amyloid plaques
• Well correlated with cell death and progression
Suggests Tau is upstream Aβ = Tau hypothesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 3 roles of microtubules in neurites?

A
  1. Structure/shape of cell
  2. Positioning of organelles
  3. Motorways for transporting
    vesicular cargo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TAU OR AMYLOID?

A

• Still really controversial!
• Probably more evidence for amyloid, but…
o Therapies based on inhibiting Aβ aggregation so far haven’t worked
• Tangles and plaques may be red herrings
o Are they pathogenic or by-standers? Or even protective?
o Oligomeric forms of Aβ and tau are more likely to be pathogenic
• Could both be downstream of other factors?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the other risk factors of AD?

A
  • Down syndrome (APP is on chromosome 21)
  • Gender (more common in women)
  • High BP, Cardiovascular disease, Diabetes
  • Low education
  • Head injury
  • Smoking and drinking
  • Only a small genetic risk contribution for late-onset AD (APOE gene status most significant)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the motor and non-motor symptoms of parkinsons disease?

A

A movement disorder, with four ‘cardinal’ features

  1. Resting tremor
  2. Bradykinesia (slow movement)
  3. Rigidity
  4. Postural instability (fall over)
NON-MOTOR SYMPTOMS
•	>90% of patients display additional non-motor symptoms, including:
o	Depression & Anxiety
o	Loss of smell
o	Sleep disorders
o	Constipation
o	Dementia 
o	Other psychiatric complications
17
Q

What are the pathological hallmarks of PD?

A

On images

PATHOLOGICAL HALLMARKS 2
Proteinopathy again!
• Lewy bodies
o Intracellular protein aggregates
o Enriched in α-synuclein protein
• Normal role of α-synuclein is poorly understood (involved in neurotransmitter release)
• Lewy bodies not pathogenic, but ↑ α-synuclein is

18
Q

Can PD be inherited?

A

• 10% of cases have a clear genetic cause
• Three rough categories
a. Early/Juvenile-onset recessive mitochondrial conditions
b. Late/later-onset (usually) autosomal dominant PD
c. Mutations that cause “PD-plus” conditions

19
Q

What is early onset mitochondrial PD?

A

o Mitochondria have a finite lifespan due to oxidative stress
o Damaged mitochondria are selectively removed from the cell by “mitophagy” – autophagy of mitochondria
o Loss-of-function mutations in two proteins central to activating mitophagy – PINK1 and Parkin – cause EO PD
 Mutations in at least 3 other genes linked to mitochondrial stress responses also linked to EO PD
o Limitation: this PD is distinct from late-onset sporadic PD
(a whole different disease?)

20
Q

What is late onset PD?

A

o Some genetic causes found from kindred studies (like EO PD), but more limited, including:
 SNCA (α-synuclein) gene amplification
• Confirms that α-synuclein is pathogenic
 LRRK2 gain-of-function
 VPS35 gain-of-function
 GBA loss-of-function

21
Q

What are GBA & α-SYNUCLEIN?

A

• GBA encodes GCase (β-glucocerebrosidase ),
a lysosomal enzyme
• α-synuclein is degraded in the lysosome
• They are connected…

22
Q

How is PD and lysosomes related?

A
  • Other PD genes play roles in processes involving lysosomes
  • Consistently, autophagy is dysregulated in PD brains.
  • Problems in autophagy will also lead to mitochondrial dysfunction (↓ mitophagy)
  • Endocytic pathways are a big focus in PD research
23
Q

What have GWAS revealed?

A
  • Risk genes
  • Has shown many “cause genes” also influence risk
  • Also found many new PD genes
  • Now believed as much as 30% of PD risk is genetic
24
Q

What are other risk factors of PD?

A
  • Gender (more common in men)
  • Red hair (~2x risk)
  • Head injury
  • Not smoking, not consuming caffeine
  • Herbicides, pesticides, insecticides
  • Exposure to metals (i.e. welder)
  • General anaesthesia
25
Q

What is neuroinflammation?

A

• Neuroinflammation = activation of the immune system within the nervous system
• In the brain, this principally means activation of microglia
(astrocytes are also involved)

26
Q

How can neuroinflammation lead to neurodegeneration?

A

On image

27
Q

What are the protective and damaging roles of microglia?

A

• Reactive microglia can be protective of neurons or damaging
• Protective
o anti-inflammatory, e.g. TGFβ
o normal removal of unhealthy cells (i.e. homeostasis)
• Damaging
o pro-inflammatory, e.g. IL-1, TNF-α
o response to pathogens etc
(i.e. damage to neurons = ‘collateral damage’)

28
Q

How is aging related to microglia?

A

Aging induces a shift towards production of damaging reactive microglia, due to changes in microglial gene expression - NEUROINFLAMMAGING

29
Q

How is PD related to the gut and brain?

A
  • Lewy body pathology in gut often precedes pathology in brain
  • Evidence that gut inflammation is sufficient to cause gut Lewy bodies
  • Spread to brain via vagus nerve?
  • Role for microbiota?
30
Q

What are the other effects of aging?

A
  • Shortening of telomeres in adult stem cells
  • Increased reactive oxygen species
  • Other changes in gene expression
  • Altered Wnt signalling is a big focus in AD and PD
  • Wnts are neuroprotective and neuromodulatory
  • Wnt/β-catenin is decreased in adult brain
  • Deregulated Wnts in developmental and geriatric neuro conditions?!